<unk>  is a<unk>  treatment plan in which drugs are given with less time between treatments than in a standard<unk>  treatment plan. The Gompertzian model of tumor cell growth shows tumor cells growing fastest when the tumor is small. When a large (slow growing) tumor is surgically removed, microtumors or individual neoplastic cells that remain will be able to grow at their fastest rate. Standard treatment may include<unk>  once every three weeks. This would allow bone marrow and gastrointestinal tract recovery before the next treatment and would inhibit the tumor for a short time, but allow rapid growth for a short time before the next treatment. By decreasing the<unk>  and increasing the frequency, the fast growth can be prevented, allowing for faster and more effective cure rate. Although the<unk>  is reduced in each treatment, the total quantity of<unk>  may or may not be increased over the duration of the typical treatment time. For example, in standard treatment of ovarian cancer, paclitaxel is given at 175 mg/m2 body surface every three weeks. In<unk><unk>  therapy paclitaxel is given at 50–80 mg/m2 every week (150–240 mg/m2 in 3-weeks).
Dose-dense chemotherapy
Sequential high-dose chemotherapy
Combination therapy
Induction chemotherapy
Multisystemic therapy
Neoadjuvant therapy
Dose fractionation
Carboxytherapy